23 results
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
that we have authorized to use in connection with this offering. We and the Sales Agents take no responsibility for, and can provide no assurance … as to the reliability of, any other information that others may give you. We and the Sales Agents take no responsibility for, and can provide no, assurance
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
present. The audit committee is not employed by the Company, nor does it provide any expert assurance or professional certification regarding the Company’s
S-3
EX-1.2
853m5yhi flrpean40o
21 Mar 24
Shelf registration
7:30am
S-3
l4k text3l
21 Mar 24
Shelf registration
7:30am
8-K
EX-10.1
pptk0mz9s90
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
10-Q
EX-31.1
c8mhrywvrkx
15 May 23
Quarterly report
5:25pm
10-Q
5dlpx3xu 9k
15 May 23
Quarterly report
5:25pm
10-Q
EX-31.2
7t01h75
15 May 23
Quarterly report
5:25pm